NSLHD News August 20

Researchers tackle one of our biggest health challenges Researchers from the Kolling Institute will support a national project to address the inappropriate pharmacists will work closely with nurses, GPs, residents and their families to provide training

use of medications in residential aged care. The initiative, to be co- ordinated by Monash University’s Centre for Medicine Use and Safety, has been awarded $2 million through the Medical Research Future Fund. It will see pharmacists embedded in residential aged care facilities, so they can implement evidence- based recommendations to improve the use of psychotropic medications in people living with dementia and in aged care. Australian research suggests more than 60 per cent of residents use psychotropic medications, like antidepressants on a regular basis, and more than 90 per cent of residents experience one or more medication-related problems. Through this project,

in managing changed behaviours and to co- ordinate education using evidence-based resources. Kolling researcher Professor Sarah Hilmer, a leading geriatrician and clinical pharmacologist has welcomed the opportunity to be part of the research team. “Importantly, this project will help implement best practice for the vulnerable people living in aged care,” she said. “It’s exciting to work with this multidisciplinary team to improve care in this complex environment.” The project will involve the New South Wales Therapeutic Advisory Group, which is chaired by Sarah. The group will lead the development of quality use of medicines indicators

Professor Sarah Hilmer

for antipsychotics, benzodiazapines and antidepressants. The four-year program will be run in partnership with the University of Queensland, Flinders University, University of Sydney and five aged care providers in Western Australia, Victoria, New South Wales and Queensland.

Kolling Institute Neuroscience and Pain Research Showcase The Kolling Institute’s Neuroscience and Pain Research Showcase is taking place on Wednesday 25 August. The showcase provides an The event will feature high profile speakers including Dr Tony Penna from the Office for Health and Medical Research and research-showcase- tickets-164057449247

the Executive Director of Sydney Health Partners Professor Don Nutbeam. Find out more information and register here: https:// www.eventbrite.com. au/e/kolling-institute- neuroscience-and-pain-

opportunity to promote our dedicated researchers and their significant achievements across neuroscience and pain research.



Made with FlippingBook - professional solution for displaying marketing and sales documents online